1- ((3- (3- chloro- 2- hydroxyproxy)- 1- methoxy)propyl)- 5- fluorouracil
a derivative of 5-fluorouracil
Also Known As:
QF-3602
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
for this Bio-Agent,
Comments
Bio-Agent Context: Research Results
Experts
| 1. | Prados, J: 1 article (09/2000) |
| 2. | Melguizo, C: 1 article (09/2000) |
| 3. | Marchal, J A: 1 article (09/2000) |
| 4. | Gómez, J A: 1 article (09/2000) |
| 5. | Gallo, M A: 1 article (09/2000) |
| 6. | Espinosa, A: 1 article (09/2000) |
| 7. | Campos, J: 1 article (09/2000) |
| 8. | Arena, N: 1 article (09/2000) |
| 9. | Aránega, A E: 1 article (09/2000) |
| 10. | Aránega, A: 1 article (09/2000) |
Related Diseases
| 1. | Rhabdomyosarcoma
09/01/2000
- "In this work, we compared the degree of myogenic differentiation of RD rhabdomyosarcoma (RMS) cells after treatment with QF-3602 and 5-FU. "
Order ALL the reference details at left... |
| 2. | Neoplasms (Cancer)
09/01/2000
- "Moreover, polymerase chain reaction (PCR) analyses showed that QF-3602 did not induce overexpression of the mdr 1 gene, a resistance mechanism that frequently appears in classical cytotoxic therapy in these tumors. "
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Fluorouracil (Carac)
|
Related Therapies and Procedures
| 1. | Aftercare (After-Treatment)
|
TREATMENT OPTIONS
for Rhabdomyosarcoma,
Ranking and Evidence
for Rhabdomyosarcoma,
Ranking and Evidence
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
- Free Updates for 1 Year
- All 97 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Evidence References
- Sample PDF Report on Psoriasis >>
| Price: | $24.95 USD
& Delivery via
PDF download
updates for 1 year |
Research Interface PRO
- Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
- Enable Experts: Quickly identify key researchers and their publications
- Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
- Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
- Research Network: Explore drug and disease relationships visually
- Enable Mobile Interface: Access from your cellphone, iPhone or PDA
| Price: | $490.00 USD
access via web interface 1 year subscription |